Loading...

Stem Holdings, Inc.

STEM.CNCNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.31
CA$0.00(0.00%)

Stem Holdings, Inc. (STEM.CN) Stock Competitors & Peer Comparison

See (STEM.CN) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
STEM.CNCA$0.31+0.00%53.6M-0.11-CA$2.79N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
BHC.TOCA$7.89-3.43%2.9B21.92CA$0.36N/A
GTII.CNCA$9.32+13.94%2.3B32.14CA$0.29N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
CURA.TOCA$1.96+3.70%1.5B-4.36-CA$0.45N/A
TRUL.CNCA$6.49+7.81%1.2B-5.95-CA$1.09N/A
CRON.TOCA$2.69-1.82%1B14.16CA$0.19N/A
TLRY.TOCA$0.80+1.27%880.4M-0.24-CA$3.38N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

STEM.CN vs CURA.CN Comparison August 2025

STEM.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, STEM.CN stands at 53.6M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, STEM.CN is priced at CA$0.31, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

STEM.CN currently has a P/E ratio of -0.11, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, STEM.CN's ROE is -2.75%, compared to CURA.CN's ROE of -0.25%. Regarding short-term risk, STEM.CN is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for STEM.CN.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;